Items where Author is "Fischer, L."

Article

Sterneck, M. and Kaiser, G. M. and Heyne, N. and Richter, N. and Rauchfuss, F. and Pascher, A. and Schemmer, P. and Fischer, L. and Klein, C. G. and Nadalin, S. and Lehner, F. and Settmacher, U. and Neuhaus, P. and Gotthardt, D. and Loss, M. and Ladenburger, S. and Paulus, E. M. and Mertens, M. and Schlitt, H. J. (2014) Everolimus and Early Calcineurin Inhibitor Withdrawal: 3-Year Results From a Randomized Trial in Liver Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 14 (3). pp. 701-710. ISSN 1600-6135, 1600-6143

Schlitt, H. J. and Mertens, M. and Fischer, L. (2013) Critical Relevance of Early Calcineurin-Inhibitor Exposure for Long-Term Renal Function After Liver Transplantation: Response to Letter by Rodriguez-Peralvarez et al. AMERICAN JOURNAL OF TRANSPLANTATION, 13 (1). p. 240. ISSN 1600-6135

Schlitt, H. and Kaiser, G. and Richter, N. and Heyne, N. and Rauchfuss, F. and Neuhaus, P. and Schemmer, P. and Fischer, L. and Paulus, E. and Mertens, M. and Sterneck, M. (2013) The PROTECT Study: 35 Months of Everolimus Monotherapy vs. Calcineurin Inhibitor-Based Therapy Showed To Be a Safe Alternative with Superior Renal Function in Liver Transplant Recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 13 (Suppl5). p. 130. ISSN 1600-6135, 1600-6143

Schlitt, H. J. and Kaiser, G. and Richter, N. and Heyne, N. and Rauchfuss, F. and Schemmee, P. and Fischer, L. and Paulus, E. -M. and Mertens, M. and Sterneck, M. (2013) The PROTECT Study: Everolimus Monotherapy vs. Calcineurin Inhibitor-Based Therapy over 35 Months Showed To Be a Safe Alternative with Superior Renal Function in Liver Transplant Recipients. LIVER TRANSPLANTATION, 19 (6Supp1). S88. ISSN 1527-6465, 1527-6473

Fischer, L. and Lehner, F. and Neuhaus, P. and Schmidt, J. and Thomas, B. and Hack, M. A. and Ladenburger, S. and Schlitt, H.J. (2012) The PROTECT Study: Preservation of Renal Function in Liver Transplant Recipients with Certican-Based vs CNI-Based Therapy. AMERICAN JOURNAL OF TRANSPLANTATION, 12 (s3). p. 125. ISSN 1600-6135

Fischer, L. and Klempnauer, J. and Beckebaum, S. and Metselaar, H. J. and Neuhaus, P. and Schemmer, P. and Settmacher, U. and Heyne, N. and Clavien, P-A and Muehlbacher, F. and Morard, I. and Wolters, H. and Vogel, W. and Becker, T. and Sterneck, M. and Lehner, F. and Klein, C. and Kazemier, G. and Pascher, A. and Schmidt, J. and Rauchfuss, F. and Schnitzbauer, A. and Nadalin, S. and Hack, M. and Ladenburger, S. and Schlitt, H. J. (2012) A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation - PROTECT. AMERICAN JOURNAL OF TRANSPLANTATION, 12 (7). pp. 1855-1865. ISSN 1600-6135

Schlitt, H. J. and Lehner, F. and Neuhaus, P. and Schmidt, J. and Becker, T. and Hack, M. A. and Ladenburger, S. and Fischer, L. (2011) THE PROTECT STUDY: PRESERVATION OF RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS WITH CERTICAN-BASED VS CNI-BASED THERAPY. TRANSPLANT INTERNATIONAL, 24 (Suppl3). p. 22. ISSN 0934-0874

Golling, M. and Becker, T. and Broelsch, C. and Candinas, D. and Faust, D. and Fischer, L. and Geissler, Edward and Graeb, C. and Iberer, F. and Klupp, J. and Kraus, T. and Mueller, A. R. and Neuhaus, P. and Strassburg, CP and Wolff, M. and Zuelke, C. and Bechstein, Wolf O. (2004) Consensus-recommendations for Sirolimus in liver transplantation. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 42 (11). pp. 1333-1340. ISSN 0044-2771

Other

Herden, U. and Nadalin, S. and Scherer, M. and Mehrabi, A. and Braun, F. and Paul, A. and Guel-Klein, S. and Pratschke, J. and Fischer, L. (2019) EXTENDED RIGHT LOBE VERSUS WHOLE ORGAN LIVER TRANSPLANTATION - GERMAN MULTICENTRE MATCHED-PAIR ANALYSIS. WILEY, HOBOKEN.

Herden, U. and Scherer, M. and Nadalin, S. and Mehrabi, A. and Braun, F. and Paul, A. and Pratschke, J. and Guel-Klein, S. and Fischer, L. and Nashan, B. (2018) High recipient MELD score has a negative influence on the outcome of right-extended split liver transplantation. LIPPINCOTT WILLIAMS & WILKINS, PHILADELPHIA.

De Simone, P. and Fischer, L. and Kaiser, G. and Jonas, S. and Heise, M. and Schemmer, P. and Pascher, A. and Schlitt, H. and Paulus, E. and Mertens, M. and Duvoux, C. (2013) EARLY EVEROLIMUS PLUS REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS RESULTS IN SUPERIOR RENAL FUNCTION AND SUSTAINS OVER 24 MONTHS: RESULTS OF A RANDOMIZED TRIAL. WILEY-BLACKWELL, HOBOKEN.

Fung, J. and Fischer, L. and Kaiser, G. and Jonas, S. and Heise, M. and Schemmer, P. and Pascher, A. and Schlitt, H. and Paulus, E. and Mertens, M. and Nevens, F. (2013) EVEROLIMUS PLUS REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS ACHIEVES COMPARABLE OVERALL EFFICACY WITH FEWER BIOPSY-PROVEN ACUTE REJECTIONS VERSUS STANDARD TACROLIMUS: 24-MONTH RESULTS OF A RANDOMIZED TRIAL. WILEY-BLACKWELL, HOBOKEN.

Schlitt, H. and Kaiser, G. and Richter, N. and Heyne, N. and Rauchfuss, F. and Pascher, A. and Schemmer, P. and Fischer, L. and Paulus, E. and Mertens, M. and Sterneck, M. (2013) THE PROTECT STUDY: EFFECT OF 35 MONTH EVEROLIMUS MONOTHERAPY VS. CALCINEURIN INHIBITOR-BASED THERAPY ON EFFICACY AND RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS. WILEY-BLACKWELL, HOBOKEN.

Sterneck, M. and Kaiser, G. and Richter, N. and Heyne, N. and Rauchfuss, F. and Neuhaus, P. and Schemmer, P. and Fischer, L. and Paulus, E. M. and Mertens, M. and Schlitt, H. J. (2013) THE PROTECT STUDY: EVEROLIMUS MONOTHERAPY vs. CALCINEURIN INHIBITOR-BASED THERAPY RESULTS IN PROGRESSIVE RENAL FUNCTION BENEFIT OVER 35 MONTHS IN LIVER TRANSPLANT RECIPIENTS. ELSEVIER SCIENCE BV, AMSTERDAM.